stage III multiple myeloma
Showing 1 - 25 of >10,000
Multiple Myeloma and Plasma Cell Tumor Trial in Buffalo (dexamethasone, doxorubicin HCl, thalidomide)
Completed
- Multiple Myeloma and Plasma Cell Neoplasm
- dexamethasone
- +3 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Sep 30, 2022
Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma Trial in Canada, United States (drug, procedure,
Active, not recruiting
- Stage I Multiple Myeloma
- +2 more
- dexamethasone
- +4 more
-
Chicago, Illinois
- +4 more
Sep 3, 2022
Multiple Myeloma in Relapse, Multiple Myeloma Progression, Multiple Myeloma Stage II Trial in London (Rivaroxaban, ASA)
Recruiting
- Multiple Myeloma in Relapse
- +5 more
-
London, Ontario, CanadaLondon Health Sciences Centre
Oct 3, 2022
Defining Clinical Potential of Mass Response asBiomarker for
Recruiting
- Stage III Breast Cancer
- +5 more
-
Columbus, GeorgiaColumbus Regional Research Institute, John B. Amos Cancer Center
Jul 13, 2022
ISS Stage I Plasma Cell Myeloma, ISS Stage II Plasma Cell Myeloma, ISS Stage III Plasma Cell Myeloma Trial in Atlanta
Active, not recruiting
- ISS Stage I Plasma Cell Myeloma
- +4 more
- Pembrolizumab
- Radiation Therapy
-
Atlanta, GeorgiaEmory University/Winship Cancer Institute
Mar 2, 2022
Refractory Multiple Myeloma, Smoldering Multiple Myeloma, Stage I Multiple Myeloma Trial in Duarte (radiation, drug, procedure,
Completed
- Refractory Multiple Myeloma
- +4 more
- total marrow irradiation
- +8 more
-
Duarte, CaliforniaCity of Hope Medical Center
Feb 25, 2021
Stage II Multiple Myeloma, Stage III Multiple Myeloma Trial in Bronx, Manhasset, New York (aflibercept)
Terminated
- Stage II Multiple Myeloma
- Stage III Multiple Myeloma
- aflibercept
-
Bronx, New York
- +5 more
Jan 29, 2021
Multiple Myeloma and Plasma Cell Tumor, Neurotoxicity Trial in Duarte (drug, genetic, other, procedure)
Completed
- Multiple Myeloma and Plasma Cell Neoplasm
- Neurotoxicity
- bortezomib
- +9 more
-
Duarte, CaliforniaCity of Hope Medical Center
Aug 17, 2021
ISS Stage III Plasma Cell Myeloma, Plasma Cell Myeloma Trial in Rochester (procedure, drug, biological)
Not yet recruiting
- ISS Stage III Plasma Cell Myeloma
- Plasma Cell Myeloma
- Bone Marrow Aspiration and Biopsy
- +7 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Aug 9, 2022
Adult Grade III Lymphomatoid Granulomatosis, B-cell Chronic Lymphocytic Leukemia, Contiguous Stage II Adult Burkitt Lymphoma
Completed
- Adult Grade III Lymphomatoid Granulomatosis
- +88 more
- bortezomib
- +2 more
-
Detroit, MichiganBarbara Ann Karmanos Cancer Institute
Apr 14, 2021
Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in
Active, not recruiting
- Accelerated Phase Chronic Myelogenous Leukemia
- +125 more
- tetanus-CMV fusion peptide vaccine
- laboratory biomarker analysis
-
Duarte, CaliforniaCity of Hope Medical Center
Feb 28, 2022
Collecting Blood Samples From and Without Cancer to Evaluate
Not yet recruiting
- Acute Lymphoblastic Leukemia
- +61 more
- Questionnaire Administration
- Biospecimen Collection
- (no location specified)
Apr 12, 2022
Multiple Myeloma and Plasma Cell Tumor Trial in United States (arsenic trioxide, dexamethasone)
Terminated
- Multiple Myeloma and Plasma Cell Neoplasm
- arsenic trioxide
- dexamethasone
-
Tucson, Arizona
- +9 more
Oct 2, 2020
Acute Biphenotypic Leukemia, Acute Erythroid Leukemia in Remission, Acute Leukemia in Remission Trial in Seattle (drug,
Terminated
- Acute Biphenotypic Leukemia
- +29 more
- Cyclophosphamide
- +7 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jan 4, 2023
Multiple Myeloma Trial in Worldwide (Carfilzomib Lenalidomide Dexamethasone, Isatuximab Carfilzomib Lenalidomide Dexamethasone)
Active, not recruiting
- Multiple Myeloma
- Carfilzomib Lenalidomide Dexamethasone
- Isatuximab Carfilzomib Lenalidomide Dexamethasone
-
Ostrava, Czechia
- +6 more
Jul 26, 2022
Prostate Cancer, Multiple Myeloma, Smoldering Multiple Myeloma (SMM) Trial in Rochester (Curcumin plus Piperine)
Recruiting
- Prostate Cancer
- +3 more
- Curcumin plus Piperine
-
Rochester, New YorkUniversity of Rochester
Jun 17, 2022
Multiple Myeloma Trial in Torino (Lenalidomide, Dexamethasone)
Active, not recruiting
- Multiple Myeloma
-
Torino, ItalyFO.NE.SA.Onlus
Mar 24, 2022
Hematopoietic/Lymphoid Cancer, Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission
Completed
- Hematopoietic/Lymphoid Cancer
- +135 more
- beclomethasone dipropionate
- +4 more
-
Hackensack, New Jersey
- +1 more
Feb 1, 2021
Multiple Myeloma in Relapse Trial in Paris (Daratumumab/Lenalidomide/Dexamethasone for 24 months,
Recruiting
- Multiple Myeloma in Relapse
- Daratumumab/Lenalidomide/Dexamethasone for 24 months
- Daratumumab/Lenalidomide/Dexamethasone until progression
-
Paris, FranceSaint Antoine Hospital - Hematology Department
Jun 10, 2022
DS Stage I Plasma Cell Myeloma, DS Stage II Plasma Cell Myeloma, DS Stage III Plasma Cell Myeloma Trial in Jacksonville,
Completed
- DS Stage I Plasma Cell Myeloma
- +3 more
- Autologous Bone Marrow Transplantation
- +4 more
-
Jacksonville, Florida
- +1 more
Aug 18, 2020
National Cancer Institute "Cancer Moonshot Biobank"
Recruiting
- Acute Myeloid Leukemia
- +33 more
- Biospecimen Collection
- Medical Chart Review
-
Kingman, Arizona
- +99 more
Nov 3, 2022
DS Stage I Plasma Cell Myeloma, DS Stage II Plasma Cell Myeloma, DS Stage III Plasma Cell Myeloma Trial in New Brunswick, Bronx,
Completed
- DS Stage I Plasma Cell Myeloma
- +3 more
- Busulfan
- +4 more
-
New Brunswick, New Jersey
- +3 more
Aug 11, 2020
Autologous Hematopoietic Stem Cell Transplant Recipient, Loss of Chromosome 17p, Plasma Cell Leukemia Trial in Duarte (drug,
Active, not recruiting
- Autologous Hematopoietic Stem Cell Transplant Recipient
- +4 more
- bortezomib
- +7 more
-
Duarte, CaliforniaCity of Hope
Mar 17, 2022